Hazard ratios for mortality and recurrence associated with lipid-lowering drug use at recruitment, compared to past or never use.

*stratified by region, adjusted for age.
**stratified by region, tumor grade, estrogen/progesterone receptor status; adjusted for age, the traditional prognostic factors tumor size, nodal status, (metastases, stage I–IV only), and for the following additional covariates evaluated using backward elimination: menopausal hormone treatment at recruitment, mode of detection, radiotherapy, and smoking. Mortality analyses are additionally adjusted for cardiovascular disease, diabetes mellitus, and body-mass index.